V-Card | Print | PDF | Email Page

Michele R. Goodman
Partner

Contact

(T) +1.202.879.5484
(F) +1.202.626.1700

Education

  • Indiana University (J.D. magna cum laude 2009; Order of the Coif; Notes and Comments Editor, Indiana Law Journal; B.S. in Psychology with honors and highest distinction 2002; Phi Beta Kappa)

Bar Admissions

  • District of Columbia, Illinois, and Georgia

Michele Goodman advises clients on compliance, regulatory, and transactional matters throughout the health care and life sciences industries. Michele frequently advises clients on fraud and abuse and transparency laws, including the False Claims Act (FCA), the Anti-Kickback Statute (AKS), and the Physician Payments Sunshine Act (Open Payments), and related issues in life sciences M&A. She also focuses on clinical trials and research collaborations, including negotiating agreements, reviewing informed consent forms, and advising on regulatory and ethical issues.

Michele has advised health care and life sciences clients on a variety of complex and novel legal matters. She has negotiated cutting-edge research alliances among academic medical centers, genomic institutes, clinical laboratories, and life sciences companies. She advised Cardinal Health on its $1.9 billion acquisition of the global Cordis business from Johnson & Johnson. Over the last several years, she also has been advising health care organizations operating in the Middle East's rapidly evolving health care sector. Additionally, Michele has experience representing organ transplant programs in proceedings before the United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services (CMS).

Michele is a member of the American Health Lawyers Association. She is also actively involved with Jones Day's Hate Crimes Task Force and its efforts to combat hate incidents in the United States. Prior to her legal career, she was a certified clinical research professional at the National Cell Repository for Alzheimer's Disease, where she gained experience in various aspects of clinical research and biospecimen repositories.


Michele Goodman